CSII

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Cardiovascular Systems Inc.

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.
CEO
David Martin
Employees
779
Headquarters

1225 Old Highway 8 NW
St Paul, Minnesota 55112-6416
Phone: 16512591600
www.csi360.com

News

How should investors view Cardiovascular Systems Inc. (CSII)?
Feb 20, 2023 18:00pm

Within its last year performance, CSII fell by -0.71%, with highs and lows ranging from $23.47 to $12.26, whereas the simple moving average jumped by 34.36% in the last 200 days. On December 21, 2022, Barclays started tracking Cardiovascular Systems Inc. (NASDAQ: CSII) recommending Equal Weight. A report published by Lake Street on December 14, […]


Source:US Post News
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Cardiovascular Systems, Inc. - CSII
Feb 14, 2023 00:41am

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered…


Source:PR Newswire
After Years Of Frustration, Cardiovascular Systems Bows Out With A Buyout (NASDAQ:CSII)
Feb 12, 2023 14:26pm

Cardiovascular Systems is selling out to Abbott for $20/share in cash. Read more to see what this means for CSII shareholders.


Source:Seeking Alpha
Cardiovascular Systems Inc. (NASDAQ: CSII): A Great Stock To Watch
Feb 10, 2023 18:00pm

Cardiovascular Systems Inc. (NASDAQ:CSII) shares, on Friday, February 10, remained unchanged to the previous day’s close as strong demand from buyers drove the stock to $19.75. Actively observing the price movement in the recent trading, the stock is buoying the session at $19.75, falling within a range of $19.69 and $19.85. The value of beta … Cardiovascular Systems Inc. (NASDAQ: CSII): A Great Stock To Watch Read More »


Source:Stocks Register
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday''s Mid-Day Session
Feb 09, 2023 17:50pm

Gainers Hempacco Co., Inc. (NASDAQ: HPCO ) rose 296% to $2.99 after declining 6% on Wednesday. Cardiovascular Systems, Inc. (NASDAQ: CSII ) shares jumped 48.6% to $19.78 following Q2 results. Abbott Laboratories agreed to acquire Cardiovascular Systems for $20 per share for an equity value of approximately $890 million. Wearable Devices Ltd. (NASDAQ: WLDS ) shares jumped 48.5% to $0.9273 after the company received approval from the Israel Innovation Authority for a $900,000 grant. SelectQuote, Inc. (NYSE: SLQT ) surged 40% to $2.1150. SelectQuote recently reported better-than-expected Q2 EPS and sales results and raised the lower end of its FY23 sales guidance above estimates. Blue Bird Corporation (NASDAQ: BLBD ) jumped 37.7% to $19.00 following upbeat quarterly sales. AppLovin Corporation (NASDAQ: APP ) shares surged 29.8% to $16.46 after the company issued strong Q1 guidance. Doma Holdings Inc. (NYSE: DOMA ) gained 24% to $0.6211. Doma Holdings is expected to report Q4 financial results after the market close on Tuesday, Feb. 28, 2023.


Source:Benzinga
Choosing between riding the trend or protecting profits: Cardiovascular Systems Inc. (CSII)
Feb 09, 2023 17:24pm

Cardiovascular Systems Inc. (CSII)’s stock is trading at $19.76 at the moment marking a rise of 48.50% from the last session close. As of this writing, shares are priced at -15.79% less than their 52-week high of $23.47, and 61.28% over their 52-week low of $12.26. Based on the past 30-day period, the stock price […]


Source:US Post News
Why Cardiovascular Systems Stock Is Soaring Today
Feb 09, 2023 16:59pm

The medtech company has agreed to a buyout offer from Abbott Laboratories.


Source:The Motley Fool
Current Stocks Alert: Cardiovascular Systems, Inc. (NASDAQ:CSII 48.38%), AT&T Inc. (NYSE:T 0.05%)
Feb 09, 2023 16:30pm

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Current Stocks Alert: Cardiovascular Systems, Inc. (NASDAQ:CSII 48.38%), AT&T Inc. (NYSE:T 0.05%) appeared first on Stocks Equity .


Source:Stock Equity
MGM Resorts, Madison Square Garden Entertainment, Cardiovascular Systems And Other Big Stocks Moving Higher On Thursday
Feb 09, 2023 16:18pm

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording losses in today’s session. Cardiovascular Systems, Inc. (NASDAQ: CSII ) shares climbed 48.6% to $19.78 following Q2 results. Abbott Laboratories agreed to acquire Cardiovascular Systems for $20 per share for an equity value of approximately $890 million. Blue Bird Corporation (NASDAQ: BLBD ) gained 37.7% to $19.00 following upbeat quarterly sales. AppLovin Corporation (NASDAQ: APP ) shares rose 29.8% to $16.46 after the company issued strong Q1 guidance. 23andMe Holding Co. (NASDAQ: ME ) jumped 17.5% to $2.96 following strong quarterly sales. Sonos, Inc. (NASDAQ: SONO ) gained 16.4% to $20.80 after the company reported better-than-expected Q1 results. QuinStreet, Inc. (NASDAQ: QNST ) rose 16% to $16.93 following strong quarterly sales. Unity Software Inc. (NYSE: U ) climbed 15.8% to $42.10. Unity Software''s mobile game publishing solution Supersonic deepened … Full story available on Benzinga.


Source:Benzinga
Abbott Adds Complementary Technologies To Its Vascular Offering Via Cardiovascular Systems Deal For $890M
Feb 09, 2023 11:57am

Abbott Laboratories (NYSE: ABT ) agrees to acquire Cardiovascular Systems Inc (NASDAQ: CSII ) for $20/share for an equity value of approximately $890 million . CSI offers devices for atherectomy, a minimally invasive treatment for plaque build-up in arteries that can restrict blood flow. Procedural use of atherectomy can help maximize the benefits of standard balloon angioplasty or stent treatments … Full story available on Benzinga.com


Source:Benzinga
Abbott to acquire Cardiovascular Systems for $20/share
Feb 09, 2023 11:34am

https://www.investing.com/news/pro/abbott-to-acquire-cardiovascular-systems-for-20share-432SI-2999237


Source:Investing.com
Cardiovascular Systems Misses Q2 EPS by 5c By Investing.com
Feb 09, 2023 10:02am

Cardiovascular Systems Misses Q2 EPS by 5c


Source:Investing.com
Cardiovascular Systems GAAP EPS of -$0.20 misses by $0.05, revenue of $61.5M misses by $3.
Feb 09, 2023 08:48am

Cardiovascular Systems press release (CSII): Q2 GAAP EPS of -$0.20 misses by $0.05.Revenue of $61.5M (+4.1% Y/Y) misses by $3.1M.The Adjusted EBITDA loss increased to $3.7M from…


Source:Seeking Alpha
Abbott (NYSE:ABT) to Fortify Medical Device Offerings with $890M Buyout
Feb 09, 2023 07:10am

Leading healthcare company Abbott (NYSE:ABT) announced the acquisition of Cardiovascular Systems (NASDAQ:CSII), a medical device maker for peripher…


Source:TipRanks
Cardiovascular Systems Q2 2023 Earnings Preview
Feb 08, 2023 16:47pm

Cardiovascular Systems (CSII) is scheduled to announce Q2 earnings results on Thursday, February 9th, before market open.The consensus EPS Estimate is -$0.15 (+34.8% Y/Y) and the…


Source:Seeking Alpha
Earnings Outlook For Cardiovascular Systems
Feb 08, 2023 16:01pm

Cardiovascular Systems (NASDAQ: CSII ) is set to give its latest quarterly earnings report on Thursday, 2023-02-09. Here''s what investors need to know before the announcement. Analysts estimate that Cardiovascular Systems will report an earnings per share (EPS) of $-0.15. Cardiovascular Systems bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com


Source:Benzinga